These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 15147370

  • 1. E4BP4 expression is regulated by the t(17;19)-associated oncoprotein E2A-HLF in pro-B cells.
    Yeung J, O'Sullivan E, Hubank M, Brady HJ.
    Br J Haematol; 2004 Jun; 125(5):560-7. PubMed ID: 15147370
    [Abstract] [Full Text] [Related]

  • 2. ABCB1 over-expression and drug-efflux in acute lymphoblastic leukemia cell lines with t(17;19) and E2A-HLF expression.
    Baudis M, Prima V, Tung YH, Hunger SP.
    Pediatr Blood Cancer; 2006 Nov; 47(6):757-64. PubMed ID: 16206189
    [Abstract] [Full Text] [Related]

  • 3. Reversal of apoptosis by the leukaemia-associated E2A-HLF chimaeric transcription factor.
    Inaba T, Inukai T, Yoshihara T, Seyschab H, Ashmun RA, Canman CE, Laken SJ, Kastan MB, Look AT.
    Nature; 1996 Aug 08; 382(6591):541-4. PubMed ID: 8700228
    [Abstract] [Full Text] [Related]

  • 4. Oncogenic fusion E2A-HLF sensitizes t(17;19)-positive acute lymphoblastic leukemia to TRAIL-mediated apoptosis by upregulating the expression of death receptors.
    Zhang X, Inukai T, Hirose K, Akahane K, Kuroda I, Honna-Oshiro H, Kagami K, Goi K, Nakamura K, Kobayashi M, Endo M, Yagita H, Kurosawa H, Thomas Look A, Honda H, Inaba T, Nakazawa S, Sugita K.
    Leukemia; 2012 Dec 08; 26(12):2483-93. PubMed ID: 22743623
    [Abstract] [Full Text] [Related]

  • 5. Characterization of the t(17;19) translocation by gene-specific fluorescent in situ hybridization-based cytogenetics and detection of the E2A-HLF fusion transcript and protein in patients' cells.
    Yeung J, Kempski H, Neat M, Bailey S, Smith O, Brady HJ.
    Haematologica; 2006 Mar 08; 91(3):422-4. PubMed ID: 16531271
    [Abstract] [Full Text] [Related]

  • 6. Pivotal role for the NFIL3/E4BP4 transcription factor in interleukin 3-mediated survival of pro-B lymphocytes.
    Ikushima S, Inukai T, Inaba T, Nimer SD, Cleveland JL, Look AT.
    Proc Natl Acad Sci U S A; 1997 Mar 18; 94(6):2609-14. PubMed ID: 9122243
    [Abstract] [Full Text] [Related]

  • 7. CREB is one component of the binding complex of the Ces-2/E2A-HLF binding element and is an integral part of the interleukin-3 survival signal.
    Chen W, Yu YL, Lee SF, Chiang YJ, Chao JR, Huang JH, Chiong JH, Huang CJ, Lai MZ, Yang-Yen HF, Yen JJ.
    Mol Cell Biol; 2001 Jul 18; 21(14):4636-46. PubMed ID: 11416141
    [Abstract] [Full Text] [Related]

  • 8. Identification of Zfp521/ZNF521 as a cooperative gene for E2A-HLF to develop acute B-lineage leukemia.
    Yamasaki N, Miyazaki K, Nagamachi A, Koller R, Oda H, Miyazaki M, Sasaki T, Honda ZI, Wolff L, Inaba T, Honda H.
    Oncogene; 2010 Apr 01; 29(13):1963-75. PubMed ID: 20062079
    [Abstract] [Full Text] [Related]

  • 9. The AD1 and AD2 transactivation domains of E2A are essential for the antiapoptotic activity of the chimeric oncoprotein E2A-HLF.
    Inukai T, Inaba T, Ikushima S, Look AT.
    Mol Cell Biol; 1998 Oct 01; 18(10):6035-43. PubMed ID: 9742120
    [Abstract] [Full Text] [Related]

  • 10. Specific induction of CD33 expression by E2A-HLF: the first evidence for aberrant myeloid antigen expression in ALL by a fusion transcription factor.
    Akahane K, Inukai T, Inaba T, Kurosawa H, Look AT, Kiyokawa N, Fujimoto J, Goto H, Endo M, Zhang X, Hirose K, Kuroda I, Honna H, Kagami K, Goi K, Nakazawa S, Sugita K.
    Leukemia; 2010 Apr 01; 24(4):865-9. PubMed ID: 20147975
    [No Abstract] [Full Text] [Related]

  • 11. Hlf, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia.
    Hunger SP, Ohyashiki K, Toyama K, Cleary ML.
    Genes Dev; 1992 Sep 01; 6(9):1608-20. PubMed ID: 1516826
    [Abstract] [Full Text] [Related]

  • 12. Aberrant induction of LMO2 by the E2A-HLF chimeric transcription factor and its implication in leukemogenesis of B-precursor ALL with t(17;19).
    Hirose K, Inukai T, Kikuchi J, Furukawa Y, Ikawa T, Kawamoto H, Oram SH, Göttgens B, Kiyokawa N, Miyagawa Y, Okita H, Akahane K, Zhang X, Kuroda I, Honna H, Kagami K, Goi K, Kurosawa H, Look AT, Matsui H, Inaba T, Sugita K.
    Blood; 2010 Aug 12; 116(6):962-70. PubMed ID: 20519628
    [Abstract] [Full Text] [Related]

  • 13. The proto-oncogene HLF and the related basic leucine zipper protein TEF display highly similar DNA-binding and transcriptional regulatory properties.
    Hunger SP, Li S, Fall MZ, Naumovski L, Cleary ML.
    Blood; 1996 Jun 01; 87(11):4607-17. PubMed ID: 8639829
    [Abstract] [Full Text] [Related]

  • 14. DNA-binding and transcriptional regulatory properties of hepatic leukemia factor (HLF) and the t(17;19) acute lymphoblastic leukemia chimera E2A-HLF.
    Hunger SP, Brown R, Cleary ML.
    Mol Cell Biol; 1994 Sep 01; 14(9):5986-96. PubMed ID: 8065331
    [Abstract] [Full Text] [Related]

  • 15. DNA-binding specificity and trans-activating potential of the leukemia-associated E2A-hepatic leukemia factor fusion protein.
    Inaba T, Shapiro LH, Funabiki T, Sinclair AE, Jones BG, Ashmun RA, Look AT.
    Mol Cell Biol; 1994 May 01; 14(5):3403-13. PubMed ID: 8164688
    [Abstract] [Full Text] [Related]

  • 16. Regulation of annexin II by cytokine-initiated signaling pathways and E2A-HLF oncoprotein.
    Matsunaga T, Inaba T, Matsui H, Okuya M, Miyajima A, Inukai T, Funabiki T, Endo M, Look AT, Kurosawa H.
    Blood; 2004 Apr 15; 103(8):3185-91. PubMed ID: 15070701
    [Abstract] [Full Text] [Related]

  • 17. The E2A-HLF oncoprotein activates Groucho-related genes and suppresses Runx1.
    Dang J, Inukai T, Kurosawa H, Goi K, Inaba T, Lenny NT, Downing JR, Stifani S, Look AT.
    Mol Cell Biol; 2001 Sep 15; 21(17):5935-45. PubMed ID: 11486032
    [Abstract] [Full Text] [Related]

  • 18. Up-regulation of survivin by the E2A-HLF chimera is indispensable for the survival of t(17;19)-positive leukemia cells.
    Okuya M, Kurosawa H, Kikuchi J, Furukawa Y, Matsui H, Aki D, Matsunaga T, Inukai T, Goto H, Altura RA, Sugita K, Arisaka O, Look AT, Inaba T.
    J Biol Chem; 2010 Jan 15; 285(3):1850-60. PubMed ID: 19887369
    [Abstract] [Full Text] [Related]

  • 19. E2A-HLF usurps control of evolutionarily conserved survival pathways.
    Seidel MG, Look AT.
    Oncogene; 2001 Sep 10; 20(40):5718-25. PubMed ID: 11607821
    [Abstract] [Full Text] [Related]

  • 20. The chimeric E2A-HLF transcription factor abrogates p53-induced apoptosis in myeloid leukemia cells.
    Altura RA, Inukai T, Ashmun RA, Zambetti GP, Roussel MF, Look AT.
    Blood; 1998 Aug 15; 92(4):1397-405. PubMed ID: 9694729
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.